MedTrace Logo

Impact of a Diabetes Camp on Glycemic Control Among Children and Adolescents Living With Type 1 Diabetes in Cameroon

NCT02632032 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2015-12-17

No results posted yet for this study

Summary

Therapeutic education is central to the management of diabetes, especially in children and adolescents. Camps represent an ideal environment for education. During camps, the campers receive both theoretical and practical information intended to improve their understanding and self-management of diabetes. The metabolic impact of diabetes camp is little known among children and adolescents living with type 1 diabetes in sub-Saharan Africa. The aimed of this study was to assess the changes in glycemic control and insulin doses in a group of children and adolescents living with type 1 diabetes in Cameroon during and after camp.

Conditions

Interventions

DRUG

Insulin

Monitoring insulin therapy of campers based on their usual regimen (one of the following): * premixed insulin in the morning and evening, * premixed insulin in the morning, regular insulin in the afternoon and premixed insulin in the evening, * regular insulin in the morning and afternoon, and premixed insulin in the evening. Education of campers on different aspects of diabetes care: * monitoring of blood glucose * injection of insulin * adaptation of insulin doses according to blood glucose and during exercise * correction of hypoglycemia * dietary advice

Sponsors & Collaborators

  • Yaounde Central Hospital

    lead OTHER_GOV

Principal Investigators

  • Mesmin Y Dehayem, MD · Yaounde Central Hospital

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Years
Max Age
23 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2013-08-31
Completion
2014-08-31

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02632032 on ClinicalTrials.gov